Edwards Lifesciences | EW - Fremdkapital

Aktienkurs
79.15
Täglich Wechseln
-2.56 -3.13%
Monatlich
-7.73%
Jährlich
15.95%
Q2 Prognose
78.61




Fremdkapital Veränderung Datum
Abbott USD 9.9B 1.7B 2025-12
Artivion USD 217.81M 2.94M 2025-12
AtriCure USD 61.86M 0 2025-12
Baxter International USD 9.47B 726M 2025-12
Becton, Dickinson and Co. USD 16.92B 705M 2025-12
Boston Scientific USD 10.99B 12M 2025-09
Cooper Companies USD 1.88B 578.5M 2025-12
Dexcom USD 1.24B 53.6M 2025-12
Edwards Lifesciences USD 598.2M 200K 2025-09
Globus Medical USD 436K 9K 2025-12
Hologic USD 2.5B 2.1M 2025-12
ICU Medical USD 1.27B 48.01M 2025-12
Inogen USD 0 0 2022-06
Insulet USD 930.8M 4.1M 2025-12
Integra LifeSciences USD 1.86B 63.76M 2025-12
Intuitive Surgical USD 0 0 2025-03
J&J USD 39.44B 30M 2025-12
Masimo USD 518M 41.1M 2025-12
Medtronic USD 27.88B 255M 2025-12
Merit Medical Systems USD 734.04M 1.12M 2025-12
Stryker USD 14.86B 14M 2025-12
Tandem Diabetes Care USD 310.04M 446K 2025-12
Teleflex USD 2.54B 30.06M 2025-12
Zimmer Biomet Holdings USD 6.93B 580.6M 2025-12